CSF proteomic signature predicts progression to Alzheimer's disease dementia.

Eleonora M VromenMarta Del Campo MilánPhilip ScheltensCharlotte E TeunissenPieter Jelle VisserBetty M Tijms

Published in: Alzheimer's & dementia (New York, N. Y.) (2022)

CSF proteome changes related to rate of progression to dementia can be detected in prodromal AD, providing more insight into processes involved in early AD pathophysiology.

Keyphrases

mild cognitive impairment
cognitive decline
cognitive impairment
parkinson disease
cerebrospinal fluid
drug induced